|
Elizabeta
Topic
 Download as a
PDF here
The Croatian Society of Medical Biochemists and Slovenian
Association for Clinical Chemistry, together with the Forum of the
European Societies of Clinical Chemistry, IFCC in Europe have
organized the third in a series of postgraduate weekend courses
entitled �New Trends in Classification and Management of
Neurological Disease� promoting continuous postgraduate education
of experts in clinical chemistry and laboratory medicine, and
ensuring the laboratory knowledge harmonization, this time on human
brain in particular.
In the past few years, scientists have made some important
breakthrough in understanding the many types of neurological
disease. These findings are now opening the way to new horizons for
diagnosing and monitoring of these disorders. Renowned experts from
European countries have participated in this specialized FESCC
Course covering the clinical and laboratory aspects of neurological
diseases.
The Course program was divided into three sections. The first
section was devoted to the cerebrovascular disease and stroke, the
leading cause of death and long term disability. The presented
topics of pathophysiology and classification of cerebrovascular
diseases; atherosclerosis and cerebrovascular disease; differential
diagnosis and prognosis markers of stroke; CSF cellular diagnostic:
from morphology to molecular biology as well as pathogenesis of
antiphospholipid syndrome are tightly related to the latest
concepts on cerebrovascular disease. The second section was focused
on infectious and neuroimmune diseases. The leading scientists in
the field reported on pathophysiology and classification of CNS
infection; multiple sclerosis; CSF analysis: disease-related data
patterns, immunoglobins and polyspecific antibody response;
nuroimmunology: immunoglobins and the intrathecal polyspecific
immune response in acute, subacute and chronic neurological
diseases; detection of oligoclonal Ig bands: clinical significance
and trends in methodological improvement; and clinical and
diagnostic role of ganglioside antibody testing. The last section
was devoted to neurodegenerative disease. The experts in the field
reviewed the pathophysiology and classification of
neurodegenerative diseases; molecular basis of Alzheimer�s disease;
Wilson disease; the endocrine brain: pathophysiological role of
neuropeptide-neurotransmitter interaction; regulatory peptides as
disease markers and molecular diagnosis of neuromuscular
disease.
At the end of this section, the training introducing PROTIS
results interpretation software for CSF assessment by Dade Behring
was organized allowing the participants to master this technique of
advanced results interpretation.
We do hope that the Course program has fulfilled its goals by
presenting the state-of-the-art and contributing to harmonization
of the classification, monitoring and management of neurological
disease.
|